Green Cross Total Liabilities
Green Cross total liabilities. Based on the latest financial reports, Green Cross (005250) has total liabilities worth ₩2.40 Trillion KRW (≈ $1.63 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Green Cross liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Green Cross (2000–2024)
Total liabilities of Green Cross from 2000 to 2024. This chart illustrates how Green Cross's total liabilities have evolved over time, based on quarterly financial data. Explore 005250 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Green Cross Competitors by Total Liabilities
The table below lists competitors of Green Cross ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
J.Jill Inc
NYSE:JILL
|
USA | $313.18 Million |
|
Accent Group Ltd
AU:AX1
|
Australia | AU$850.23 Million |
|
Instone Real Estate Group AG
XETRA:INS
|
Germany | €1.17 Billion |
|
Jiangsu Yuxing Film Tech
SHE:300305
|
China | CN¥1.30 Billion |
|
Kingstone Companies Inc
NASDAQ:KINS
|
USA | $348.77 Billion |
|
Dadelo S.A.
WAR:DAD
|
Poland | zł309.55 Million |
|
Asflow Co. Ltd.
KQ:159010
|
Korea | ₩72.08 Billion |
|
Horizon Technology Finance
NASDAQ:HRZN
|
USA | $457.78 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Green Cross's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Green Cross (005250) total assets.
Liquidity & Leverage Metrics
Green Cross Total Liabilities Ratios Explained
Green Cross total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Green Cross's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Green Cross (2000–2024)
The table below shows the annual total liabilities of Green Cross from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩1.82 Trillion ≈ $1.23 Billion |
-2.03% |
| 2023-12-31 | ₩1.86 Trillion ≈ $1.26 Billion |
+14.22% |
| 2022-12-31 | ₩1.63 Trillion ≈ $1.10 Billion |
+2.45% |
| 2021-12-31 | ₩1.59 Trillion ≈ $1.07 Billion |
+1.17% |
| 2020-12-31 | ₩1.57 Trillion ≈ $1.06 Billion |
+23.71% |
| 2019-12-31 | ₩1.27 Trillion ≈ $858.81 Million |
+7.81% |
| 2018-12-31 | ₩1.18 Trillion ≈ $796.61 Million |
+4.86% |
| 2017-12-31 | ₩1.12 Trillion ≈ $759.70 Million |
+28.52% |
| 2016-12-31 | ₩872.27 Billion ≈ $591.12 Million |
+16.10% |
| 2015-12-31 | ₩751.28 Billion ≈ $509.13 Million |
+23.20% |
| 2014-12-31 | ₩609.81 Billion ≈ $413.26 Million |
+16.27% |
| 2013-12-31 | ₩524.46 Billion ≈ $355.42 Million |
+10.76% |
| 2012-12-31 | ₩473.51 Billion ≈ $320.89 Million |
-87.23% |
| 2011-12-31 | ₩3.71 Trillion ≈ $2.51 Billion |
+13.33% |
| 2010-12-31 | ₩3.27 Trillion ≈ $2.22 Billion |
+15.89% |
| 2009-12-31 | ₩2.82 Trillion ≈ $1.91 Billion |
+16.03% |
| 2008-12-31 | ₩2.43 Trillion ≈ $1.65 Billion |
+16.94% |
| 2007-12-31 | ₩2.08 Trillion ≈ $1.41 Billion |
+16.23% |
| 2006-12-31 | ₩1.79 Trillion ≈ $1.21 Billion |
+17.08% |
| 2005-12-31 | ₩1.53 Trillion ≈ $1.04 Billion |
+8.28% |
| 2004-12-31 | ₩1.41 Trillion ≈ $956.82 Million |
+1.32% |
| 2003-12-31 | ₩1.39 Trillion ≈ $944.32 Million |
+643.13% |
| 2002-12-31 | ₩187.51 Billion ≈ $127.07 Million |
-13.78% |
| 2001-12-31 | ₩217.49 Billion ≈ $147.39 Million |
+44.18% |
| 2000-12-31 | ₩150.84 Billion ≈ $102.22 Million |
-- |
About Green Cross
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more